EE189 CAPOX versus mFOLFOX as Adjuvant Chemotherapy in Patients with Stage 3 Colon Cancer: A Cost-Effectiveness Study
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.438
https://www.valueinhealthjournal.com/article/S1098-3015(22)00639-8/fulltext
Title :
EE189 CAPOX versus mFOLFOX as Adjuvant Chemotherapy in Patients with Stage 3 Colon Cancer: A Cost-Effectiveness Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00639-8&doi=10.1016/j.jval.2022.04.438
First page :
Section Title :
Open access? :
No
Section Order :
10385